Plasma Hemoglobin and Red Blood Cell Mass Levels as Dynamic Prognostic Markers for Progression and Survival in Pancreatic Neuroendocrine Tumors

In conclusion, decrease in red blood cells mass, hemoglobin and/or hematocrit levels are all associated with poor prognosis in patients with pancreatic neuroendocrine tumors. We suggest utilizing these parameters as complementary follow-up prognostic markers to radiologic imaging in this patients population. [...] Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Hormone and Metabolic Research - December 10, 2021 Category: Endocrinology Authors: Halperin, Reut Ahron-Hananel, Genya Badarna, Muhamad Greidinger, Dahlia Uri, Inbal Percik, Ruth Tirosh, Amit Tags: Endocrine Care Source Type: research